Fertilization in Vitro, Single Embryo Transfer
Conditions
Brief summary
Despite technical advances in Medically Assisted Reproduction (AMP), the success of fertility treatments is sometimes limited by embryo implantation failure. The coordinated development of the embryo and the uterine endometrium requires close communication between the maternal tissue and the embryo. In in vitro fertilization (IVF), embryo transfer generally takes place between the 2nd (D2) and the 6th (D6) day following oocyte fertilization. Recent studies have shown the advantages of sequential transfer (transfer of an embryo on D2/D3 followed by the transfer of another embryo on D5/D6), with higher implantation and clinical pregnancy rate, fewer miscarriages, more live births, and yet no increase in multiple pregnancies. However, the American Society for Reproductive Medicine recommendations continue to prioritize the transfer of a single embryo for all patients aged under 38. To improve pregnancy rates for patients having a single embryo transferred, the study investigators wish to carry out on blank transfer, based on the principle of sequential transfer. The study investigators hypothesize that a culture medium, placed in the uterus before the time of embryo transfer, will modify immune tolerance. The study will test whether transferring the same culture medium in an equivalent quantity as during the real transfer into the uterus 2/3 days before the embryo transfer will improve tolerance to this foreign medium and, therefore, embryo implantation. The aim of this study is thus to evaluate the impact of a blank transfer with culture medium alone, on the results of frozen embryo transfers (FET) from IVF.
Interventions
A maximum of 0.1 ml of gassed embryo culture medium preheated to 37°C is injected into the uterine cavity transcervically using an embryo transfer catheter placed just beyond the internal os, two to 3 days before transfer of the thawed embryo
An intermediate transfer step is added two or three days before the planned transfer of the frozen embryo but with an empty catheter.
Sponsors
Study design
Eligibility
Inclusion criteria
* Having had a first fresh or frozen embryo transfer, whatever the embryo's stage of development, transfer followed by pregnancy failure ; * Frozen embryos must be at least D3 stage; * The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan
Exclusion criteria
* The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study * The patient is under safeguard of justice or state guardianship
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinically progressive pregnancy rate between groups | 12 weeks of amenorrhea | Measured on first-trimester ultrasound |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Occurrence of a biochemical pregnancy between groups | Day 14 | Defined by a positive beta HCG test ≥ 10 IU/ml and \< 100 IU/ml |
| Occurrence of a clinical pregnancy between groups | 6 weeks of amenorrhea | Defined by a positive beta HCG test ≥ 100 IU/ml and presence of at least one gestational sac on dating ultrasound |
| Occurrence of an early miscarriage between groups | 12 weeks of amenorrhea | Defined by the presence of a pregnancy defined by a positive beta HCG test ≥ 100 IU at D14 and the absence of an evolving clinical pregnancy at first-trimester ultrasound |
| Occurrence of pregnancy between groups | Day 14 | Defined by a positive beta HCG test ≥ 100 IU/ml |
| Differential cost-result ratio | End of study (Year 3) | Ratio of the cost differential and the number of additional live births (additional progressive clinical pregnancies) between the two strategies, to evaluate the cost per additional live birth. |
| Total estimated expenditure for the two care strategies compared (budget impact analysis) over a one-year time horizon. | End of study (Year 3) | Calculated at national level (implementation of the system and consumption of care) |
| Occurrence of live birth | Upon giving birth (maximum month 9) | Yes/no |
Countries
France, Reunion